Bajaj Healthcare Limited (BAJAJHCARE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bajaj Healthcare Limited (BAJAJHCARE) has a cash flow conversion efficiency ratio of 0.103x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs501.85 Million ≈ $5.43 Million USD) by net assets (Rs4.86 Billion ≈ $52.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BAJAJHCARE equity financing ratio to measure how much of total assets are equity-financed.
Bajaj Healthcare Limited - Cash Flow Conversion Efficiency Trend (2011–2026)
This chart illustrates how Bajaj Healthcare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Bajaj Healthcare Limited (BAJAJHCARE) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Bajaj Healthcare Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bajaj Healthcare Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Amber International Holding Limited
NASDAQ:AMBR
|
-0.008x |
|
Jalles Machado S/A
SA:JALL3
|
0.104x |
|
Rav Bariach 08 Industries Ltd
TA:BRIH
|
0.051x |
|
Cosmax Nbt Inc
KQ:222040
|
0.204x |
|
Merit Turizm Yatirim ve Isletme AS
IS:MERIT
|
0.006x |
|
Servotronics Inc
NYSE MKT:SVT
|
-0.067x |
|
YFC-BonEagle Electric Co Ltd
TWO:6220
|
0.174x |
|
vTv Therapeutics Inc
NASDAQ:VTVT
|
0.102x |
Annual Cash Flow Conversion Efficiency for Bajaj Healthcare Limited (2011–2026)
The table below shows the annual cash flow conversion efficiency of Bajaj Healthcare Limited from 2011 to 2026. For the full company profile with market capitalisation and key ratios, see BAJAJHCARE market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs5.33 Billion ≈ $57.64 Million |
Rs372.23 Million ≈ $4.03 Million |
0.070x | +663.44% |
| 2025-03-31 | Rs4.66 Billion ≈ $50.41 Million |
Rs-57.78 Million ≈ $-624.87K |
-0.012x | -103.74% |
| 2024-03-31 | Rs2.78 Billion ≈ $30.10 Million |
Rs922.94 Million ≈ $9.98 Million |
0.332x | +646.11% |
| 2023-03-31 | Rs3.68 Billion ≈ $39.76 Million |
Rs-223.24 Million ≈ $-2.41 Million |
-0.061x | -3007.22% |
| 2022-03-31 | Rs3.28 Billion ≈ $35.52 Million |
Rs6.86 Million ≈ $74.19K |
0.002x | -98.76% |
| 2021-03-31 | Rs2.58 Billion ≈ $27.95 Million |
Rs435.58 Million ≈ $4.71 Million |
0.169x | +24.21% |
| 2020-03-31 | Rs1.52 Billion ≈ $16.40 Million |
Rs205.75 Million ≈ $2.23 Million |
0.136x | -30.38% |
| 2019-03-31 | Rs1.29 Billion ≈ $13.96 Million |
Rs251.69 Million ≈ $2.72 Million |
0.195x | +33.31% |
| 2018-03-31 | Rs1.14 Billion ≈ $12.29 Million |
Rs166.14 Million ≈ $1.80 Million |
0.146x | -37.16% |
| 2017-03-31 | Rs990.00 Million ≈ $10.71 Million |
Rs230.39 Million ≈ $2.49 Million |
0.233x | -17.95% |
| 2016-03-31 | Rs886.32 Million ≈ $9.59 Million |
Rs251.38 Million ≈ $2.72 Million |
0.284x | -60.35% |
| 2015-03-31 | Rs390.72 Million ≈ $4.23 Million |
Rs279.51 Million ≈ $3.02 Million |
0.715x | +29.24% |
| 2014-03-31 | Rs315.57 Million ≈ $3.41 Million |
Rs174.68 Million ≈ $1.89 Million |
0.554x | +12.94% |
| 2013-03-31 | Rs295.85 Million ≈ $3.20 Million |
Rs145.00 Million ≈ $1.57 Million |
0.490x | +74.79% |
| 2012-03-31 | Rs306.41 Million ≈ $3.31 Million |
Rs85.92 Million ≈ $929.15K |
0.280x | +86.89% |
| 2011-03-31 | Rs299.91 Million ≈ $3.24 Million |
Rs44.99 Million ≈ $486.60K |
0.150x | -- |
About Bajaj Healthcare Limited
Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company offers active pharmaceutical ingredient in various therapeutic categories, including anti-diabetic, antibiotic, … Read more